Literature DB >> 23983957

Increased plasma norepinephrine concentration in psychotic depression.

Jaap G Goekoop, Remco F P de Winter, Ron Wolterbeek, Godfried M J Van Kempen, Victor M Wiegant.   

Abstract

OBJECTIVE: We previously found psychotic depression (PSDEP) to have positively correlating plasma norepinephrine (NE) and vasopressin (AVP) concentrations. Since central noradrenergic activity and plasma NE concentration are highly correlated, this suggests an increased noradrenergic activation of the hypothalamus-pituitary-adrenal axis. We hypothesize the increased release of NE in PSDEP to be an associated mechanism.
METHODS: To test this hypothesis we analyzed the relation between plasma NE and PSDEP in a comparison with non-psychotically depressed patients. Potentially confounding variables were, among others, melancholia and two better validated subcategories in the field of melancholia and endogenous depression, three global dimensions of psychopathology - Emotional Dysregulation, Retardation and Anxiety - smoking habit, and different types of psychotropic and particularly antidepressant treatment. The data from nine patients with PSDEP and 69 patients with non-PSDEP were reanalysed.
RESULTS: Analysis of covariance controlling for the effects of tricyclic antidepressant treatment (≥100 mg) and smoking habit showed that PSDEP had an increased concentration of plasma NE. The previously found correlation between plasma NE and AVP was still present after correcting for the effects of confounding variables.
CONCLUSIONS: The results suggest an increased activity of the sympathetic nervous system in PSDEP that may act as a specific mechanism for increased vasopressinergic activation. This supports the view of PSDEP as a distinct subcategory of major depression.

Entities:  

Keywords:  norepinephrine; psychotic depression; smoking; tricyclic antidepressant; vasopressin

Year:  2012        PMID: 23983957      PMCID: PMC3736933          DOI: 10.1177/2045125312436574

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN: 2045-1253


  55 in total

1.  The hierarchy model of psychiatric symptomatology: an investigation based on present state examination ratings.

Authors:  P G Surtees; R E Kendell
Journal:  Br J Psychiatry       Date:  1979-11       Impact factor: 9.319

2.  Relationship between norepinephrine in blood and cerebrospinal fluid in the presence of a blood-cerebrospinal fluid barrier for norepinephrine.

Authors:  M G Ziegler; C R Lake; J H Wood; B R Brooks; M H Ebert
Journal:  J Neurochem       Date:  1977-03       Impact factor: 5.372

3.  DST studies in psychotic depression: a meta-analysis.

Authors:  J C Nelson; J M Davis
Journal:  Am J Psychiatry       Date:  1997-11       Impact factor: 18.112

4.  Plasma noradrenaline response to electroconvulsive therapy in depressive illness.

Authors:  C B Kelly; S J Cooper
Journal:  Br J Psychiatry       Date:  1997-08       Impact factor: 9.319

Review 5.  The involvement of the vasopressin system in stress-related disorders.

Authors:  Rainer Landgraf
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-04       Impact factor: 4.388

Review 6.  Overview: toward a dysregulation hypothesis of depression.

Authors:  L J Siever; K L Davis
Journal:  Am J Psychiatry       Date:  1985-09       Impact factor: 18.112

Review 7.  Brain corticosteroid receptor balance in health and disease.

Authors:  E R De Kloet; E Vreugdenhil; M S Oitzl; M Joëls
Journal:  Endocr Rev       Date:  1998-06       Impact factor: 19.871

8.  Cortical alpha-adrenoceptor downregulation by tricyclic antidepressants in the rat brain.

Authors:  M N Subhash; M R Nagaraja; S Sharada; K Y Vinod
Journal:  Neurochem Int       Date:  2003-12       Impact factor: 3.921

9.  Differences and variability in plasma noradrenaline between depressive and anxiety disorders.

Authors:  C B Kelly; S J Cooper
Journal:  J Psychopharmacol       Date:  1998       Impact factor: 4.153

10.  Dopamine beta hydroxylase (DBH) plasma activity in childhood mental disorders.

Authors:  Ivo Paclt; Jitka Koudelová; Dagmar Pacltova; Marta Kopeckova
Journal:  Neuro Endocrinol Lett       Date:  2009       Impact factor: 0.765

View more
  4 in total

1.  Breakfast skipping alone and in interaction with inflammatory based quality of diet increases the risk of higher scores of psychological problems profile in a large sample of Iranian adults.

Authors:  Fahimeh Haghighatdoost; Awat Feizi; Ahmad Esmaillzadeh; Ammar Hassanzadeh Keshteli; Hamid Afshar; Peyman Adibi
Journal:  J Nutr Sci       Date:  2021-02-16

2.  Dose-Dependent Acute Effects of Everolimus Administration on Immunological, Neuroendocrine and Psychological Parameters in Healthy Men.

Authors:  Tina Hörbelt; Anna Lena Kahl; Frederike Kolbe; Susann Hetze; Benjamin Wilde; Oliver Witzke; Manfred Schedlowski
Journal:  Clin Transl Sci       Date:  2020-05-31       Impact factor: 4.689

3.  Bio-behavioural changes in treatment-resistant socially isolated FSL rats show variable or improved response to combined fluoxetine-olanzapine versus olanzapine treatment.

Authors:  K Mncube; B H Harvey
Journal:  IBRO Neurosci Rep       Date:  2022-09-05

4.  Drinking plain water is associated with decreased risk of depression and anxiety in adults: Results from a large cross-sectional study.

Authors:  Fahimeh Haghighatdoost; Awat Feizi; Ahmad Esmaillzadeh; Nafiseh Rashidi-Pourfard; Ammar Hassanzadeh Keshteli; Hamid Roohafza; Payman Adibi
Journal:  World J Psychiatry       Date:  2018-09-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.